These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 8823419

  • 21. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V, Molica S, Capalbo S, Pogliani E, Battista C, Broccia G, Montillo M, Cuneo A, Leoni P, Specchia G, Castoldi G.
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [Abstract] [Full Text] [Related]

  • 22. A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
    Byrd JC, Peterson B, Piro L, Saven A, Vardiman JW, Larson RA, Schiffer C.
    Leukemia; 2003 Feb; 17(2):323-7. PubMed ID: 12592330
    [Abstract] [Full Text] [Related]

  • 23. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
    Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB.
    Blood; 1989 Jul; 74(1):19-25. PubMed ID: 2473795
    [Abstract] [Full Text] [Related]

  • 24. Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine.
    Montillo M, Cafro AM, Tedeschi A, Brando B, Oreste P, Veronese S, Rossi V, Cairoli R, Pungolino E, Morra E.
    Haematologica; 2002 Jul; 87(7):695-700; discussion 700. PubMed ID: 12091119
    [Abstract] [Full Text] [Related]

  • 25. Astrovirus enteritis in a chronic lymphocytic leukemia patient treated with fludarabine monophosphate.
    Coppo P, Scieux C, Ferchal F, Clauvel J, Lassoued K.
    Ann Hematol; 2000 Jan; 79(1):43-5. PubMed ID: 10663621
    [Abstract] [Full Text] [Related]

  • 26. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
    Arima N, Mizoguchi H, Shirakawa S, Tomonaga M, Takatsuki K, Ohno R.
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):619-29. PubMed ID: 10234292
    [Abstract] [Full Text] [Related]

  • 27. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
    [No Abstract] [Full Text] [Related]

  • 28. [Experience with fludarabine treatment and review of the literature].
    Telek B, Rejtó L, Kiss A, Batár P, Reményi G, Rák K, Udvardy M.
    Orv Hetil; 2002 Jun 16; 143(24):1459-65. PubMed ID: 12138643
    [Abstract] [Full Text] [Related]

  • 29. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Solal-Céligny P, Brice P, Brousse N, Caspard H, Bastion Y, Haïoun C, Bosly A, Tilly H, Bordessoule D, Sebban C, Harousseau JL, Morel P, Dupas B, Plassart F, Vasile N, Fort N, Leporrier M.
    J Clin Oncol; 1996 Feb 16; 14(2):514-9. PubMed ID: 8636765
    [Abstract] [Full Text] [Related]

  • 30. Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia.
    Schilling PJ, Vadhan-Raj S.
    N Engl J Med; 1990 Sep 20; 323(12):833-4. PubMed ID: 1697401
    [No Abstract] [Full Text] [Related]

  • 31. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK, Grever MR, Beer M, Lucas MA, Byrd JC.
    Semin Oncol; 2000 Apr 20; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [Abstract] [Full Text] [Related]

  • 32. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA.
    N Engl J Med; 2000 Dec 14; 343(24):1750-7. PubMed ID: 11114313
    [Abstract] [Full Text] [Related]

  • 33. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
    Binet JL.
    Nouv Rev Fr Hematol (1978); 1993 Feb 14; 35(1):5-7. PubMed ID: 7685518
    [Abstract] [Full Text] [Related]

  • 34. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
    Foran JM, Rohatiner AZ, Coiffier B, Barbui T, Johnson SA, Hiddemann W, Radford JA, Norton AJ, Tollerfield SM, Wilson MP, Lister TA.
    J Clin Oncol; 1999 Feb 14; 17(2):546-53. PubMed ID: 10080598
    [Abstract] [Full Text] [Related]

  • 35. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
    Bergmann L.
    Leukemia; 1997 Apr 14; 11 Suppl 2():S29-34. PubMed ID: 9178835
    [Abstract] [Full Text] [Related]

  • 36. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
    Gershanovich ML, Zaritskiĭ AIu, Medvedeva NV, Abdulkadyrov KM, Samuskevich IG, Beresneva IA.
    Vopr Onkol; 1998 Apr 14; 44(6):696-700. PubMed ID: 10087967
    [Abstract] [Full Text] [Related]

  • 37. Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
    Prescrire Int; 2005 Feb 14; 14(75):3-5. PubMed ID: 15747447
    [Abstract] [Full Text] [Related]

  • 38. A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia.
    Weiss MA.
    Semin Oncol; 2000 Apr 14; 27(2 Suppl 5):41-3. PubMed ID: 10877051
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.